Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.74 USD
Change Today -0.18 / -1.81%
Volume 61.7K
CGIX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 4:00 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hans-Guido Wendel M.D.

Member of Scientific Advisory Board,Cancer Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Hans-Guido Wendel, M.D. is a Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that improves the care of cancer patients. Dr. Wendel has been Member of Scientific Advisory Committee at Egenix, Inc. since May 2014. He serves as a Member of Scientific Advisory Board at Cancer Genetics, ...

Read Full Background

Corporate Headquarters*

201 Route 17 North
Rutherford, New Jersey 07070

United States

Phone: 201-528-9200
Fax: 201-528-9201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Rheinisch-Westfälische Technische Hochschule Aachen

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGIX:US $9.74 USD -0.18

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$767.9K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANCER GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.